Paper6633596
Progesterone receptors as a prognostic factor in Stage II breast cancer.
Clark GM and 4 others. N Engl J Med, 1983. Cited by 417 papers, by iCite.
Cite this record
ConductScience Library. Progesterone receptors as a prognostic factor in Stage II breast cancer. Papers, record 6633596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6633596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Receptors, Progesterone | Major topic |
| Female | |
| Humans | |
| Lymphatic Metastasis | |
| Neoplasm Staging | |
| Prognosis | |
| Receptors, Estrogen | |
| Statistics as Topic |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 30195 | NCI NIH HHS | United States | P01CA030195 | PubMed and NIH | NIH RePORTER |
| CB 23922 | NCI NIH HHS | United States | PubMed | PubMed |
Cited by78
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 417 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35201434 | The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer. | Discov Oncol | 2021 | https://conductscience.org/library/papers/35201434 | PubMed |
| 33613796 | Percentage of Hormone Receptor Positivity in Breast Cancer Provides Prognostic Value: A Single-Institute Study. | J Clin Med Res | 2021 | https://conductscience.org/library/papers/33613796 | PubMed |
| 30407916 | Low PR in ER(+)/HER2(-) breast cancer: high rates of TP53 mutation and high SUV. | Endocr Relat Cancer | 2019 | https://conductscience.org/library/papers/30407916 | PubMed |
| 30312199 | Implications for Breast Cancer Restaging Based on the 8th Edition AJCC Staging Manual. | Ann Surg | 2020 | https://conductscience.org/library/papers/30312199 | PubMed |
| 29435103 | Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling. | Oncotarget | 2018 | https://conductscience.org/library/papers/29435103 | PubMed |
| 28861319 | Steroid hormone receptors as prognostic markers in breast cancer. | Am J Cancer Res | 2017 | https://conductscience.org/library/papers/28861319 | PubMed |
| 28569250 | Interleukin 8 in progression of hormone-dependent early breast cancer. | J Biosci | 2017 | https://conductscience.org/library/papers/28569250 | PubMed |
| 27872526 | Progesterone Receptors, Pathological Complete Response and Early Outcome for Locally Advanced Breast Cancer - a Single Centre Study. (PPLB - 01). | Indian J Surg Oncol | 2016 | https://conductscience.org/library/papers/27872526 | PubMed |
| 25998416 | From bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer? | J Steroid Biochem Mol Biol | 2015 | https://conductscience.org/library/papers/25998416 | PubMed |
| 25268975 | Synthesis, characterization and in vitro study of biocompatible cinnamaldehyde functionalized magnetite nanoparticles (CPGF Nps) for hyperthermia and drug delivery applications in breast cancer. | PLoS One | 2014 | https://conductscience.org/library/papers/25268975 | PubMed |
| 24906430 | HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer. | Breast Cancer Res Treat | 2014 | https://conductscience.org/library/papers/24906430 | PubMed |
| 24637666 | Inferring gene dependency network specific to phenotypic alteration based on gene expression data and clinical information of breast cancer. | PLoS One | 2014 | https://conductscience.org/library/papers/24637666 | PubMed |
| 24527034 | Breast cancer pathology, receptor status, and patterns of metastasis in a rural appalachian population. | J Cancer Epidemiol | 2014 | https://conductscience.org/library/papers/24527034 | PubMed |
| 24199171 | In situ Protein Detection for Companion Diagnostics. | Front Oncol | 2013 | https://conductscience.org/library/papers/24199171 | PubMed |
| 23251644 | Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. | PLoS One | 2012 | https://conductscience.org/library/papers/23251644 | PubMed |
| 22108646 | The association between vitamin D receptor expression and prolonged overall survival in breast cancer. | J Histochem Cytochem | 2012 | https://conductscience.org/library/papers/22108646 | PubMed |
| 21459801 | Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21459801 | PubMed |
| 20150438 | Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome. | Am J Pathol | 2010 | https://conductscience.org/library/papers/20150438 | PubMed |
| 19701242 | Biological determinants of endocrine resistance in breast cancer. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19701242 | PubMed |
| 19064545 | Triple-negative breast cancer and obesity in a rural Appalachian population. | Cancer Epidemiol Biomarkers Prev | 2008 | https://conductscience.org/library/papers/19064545 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6633596
GET https://conductscience.org/api/papers/v1/6633596/cited_by?page=2